Wills Robert James

CIK 00016341894 companiesMONTREAL, A8

SEC Profile

Transactions

Companies

Filings

CIK

0001634189

Recent Transactions

50 trades

Purchase
Alpha Cognition Inc.$ACOG
Common Stock
2025-08-18$8.49/sh+15,000→ 15,000 total
Award
Milestone Pharmaceuticals Inc.$MIST
Series A Common Warrants (right to buy)
2025-07-11+50,000→ 50,000 total
Award
Milestone Pharmaceuticals Inc.$MIST
Common Shares
2025-07-11+50,000→ 65,000 total
Award
Milestone Pharmaceuticals Inc.$MIST
Series B Common Warrants (right to buy)
2025-07-11+50,000→ 50,000 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2025-06-10+40,000→ 40,000 total
Award
Alpha Cognition Inc.$ACOG
Director Stock Option (Right to Buy)
2025-04-07+30,019→ 30,019 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2024-08-28+40,000→ 40,000 total
Award
Oncternal Therapeutics, Inc.
Stock Options
2024-06-20+2,200→ 2,200 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2024-04-08$8.96/sh+3,086→ 10,000 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2024-03-28$8.48/sh+6,914→ 6,914 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−9,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−7,500→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−32,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−25,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−25,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−27,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−67,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−14,010→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Common Stock
2024-03-22−30,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−15,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−16,000→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−27,705→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−49,245→ 0 total
Disposition to Issuer
CymaBay Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-03-22−18,000→ 0 total
Sale
Oncternal Therapeutics, Inc.
Common Stock
2024-02-23$9.04/sh−980→ 0 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2024-01-24+14,010→ 14,010 total
Award
Oncternal Therapeutics, Inc.
Stock Options
2023-06-28+25,000→ 25,000 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2023-06-07+30,000→ 30,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2023-01-25+25,000→ 25,000 total
Purchase
Milestone Pharmaceuticals Inc.$MIST
Common Shares
2022-10-19$4.93/sh+15,000→ 15,000 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2022-07-05+30,000→ 30,000 total
Award
Oncternal Therapeutics, Inc.
Stock Options
2022-06-16+25,000→ 25,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2022-01-25+67,000→ 67,000 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2021-06-14+30,000→ 30,000 total
Award
Oncternal Therapeutics, Inc.
Stock Options
2021-05-25+25,000→ 25,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2021-01-26+32,000→ 32,000 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2020-10-01+30,000→ 30,000 total
Award
Oncternal Therapeutics, Inc.
Stock Options
2020-06-11−15,000→ 15,000 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2020-06-11+15,000→ 15,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (Right to Buy)
2020-05-15+49,245→ 49,245 total
Award
Oncternal Therapeutics, Inc.
Stock Option
2019-09-12−30,000→ 30,000 total
Award
Oncternal Therapeutics, Inc.
Stock Options
2019-09-12+30,000→ 30,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2019-01-29+27,705→ 27,705 total
Purchase
Oncternal Therapeutics, Inc.
Common Stock
2018-06-26$16.75/sh+5,000→ 137,344 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2018-01-24+16,000→ 16,000 total
Award
Oncternal Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2018-01-01+65,000→ 65,000 total
Award
CymaBay Therapeutics, Inc.
Stock Option (right to buy)
2017-09-22+7,500→ 7,500 total
Purchase
CymaBay Therapeutics, Inc.
Common Stock
2017-08-01$6.84/sh+300→ 25,500 total
Purchase
CymaBay Therapeutics, Inc.
Common Stock
2017-08-01$6.83/sh+200→ 25,200 total
Purchase
CymaBay Therapeutics, Inc.
Common Stock
2017-08-01$6.84/sh+1,000→ 26,500 total

Companies

Recent Filings

Address

C/O MILESTONE PHARMACEUTICALS INC. 1111 DR. FREDERIK-PHILIPS BLVD, STE 420

MONTREAL, A8, H4M 2X6

View on SEC.gov